Bayer Receives National Organization of Rare Disorders (NORD) Honor at “Portraits of Courage” Celebration
WHIPPANY, N.J., May 9, 2014 /PRNewswire/ — Bayer HealthCare was honored by the National Organization for Rare Disorders (NORD) at their annual “Portraits of Courage” Celebration in Washington, DC on May 8. The event recognized several individuals, foundations and innovator companies that have made substantial contributions to improving the lives of people affected by rare disorders.
NORD’s celebration of progress is an annual event open to everyone with an interest in rare diseases and orphan products. Approximately 500 people attend each year, representing a cross-section of the rare disease community – medical clinicians and researchers, patients and patient advocates, and individuals from government, academia and the pharmaceutical industry.
“Bayer has a long-standing commitment to in the area of rare diseases, which has resulted in treatments for rare conditions such as, hemophilia A and rare forms of cancer,” said NORD President and CEO Peter L. Saltonstall. “We are pleased to recognize Bayer for their continued efforts to bring forth new treatment options for orphan diseases.”
“It is an honor to be recognized by NORD for our work in the treatment of severe and life threatening forms of pulmonary hypertension,” said Eric Curtis, Vice President and General Manager, CardioPulmonary, Bayer Healthcare.
About Bayer HealthCare Pharmaceuticals Inc.
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world’s leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions. As a specialty pharmaceutical company, Bayer HealthCare provides products for General Medicine, Hematology, Neurology, Oncology and Women’s Healthcare. The company’s aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.
About National Organization for Rare Disorders
The National Organization for Rare Disorders (NORD), a 501(c)(3) organization, is a unique federation of voluntary health organizations dedicated to helping people with rare “orphan” diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Intended for U.S. media only
SOURCE Bayer HealthCare